Genetic ancestry may play a key role in how acral melanoma, a rare and aggressive type of skin cancer, develops and behaves, ...

From "cumulative" health risks in men to the lack of residency training, Dr. Michael Christopher breaks down why dedicated skin checks are a necessity.

Oregon State University researchers have developed a new nanoparticle-based photothermal therapy that uses a low-power laser ...

Genetic ancestry may play a key role in how acral melanoma, a rare and aggressive type of skin cancer, develops and behaves, ...

Decreases in circulating tumor DNA (ctDNA) within the first month of immune checkpoint inhibitor (ICI) therapy were strongly ...

71 percent of patients had pathological complete response; 7 percent experienced grade 3 treatment-related adverse events.

Genetic ancestry may play a key role in how acral melanoma, a rare and aggressive type of skin cancer, develops and behaves, with important ...

A near-infrared light beam appears harmless, as it is a low-frequency type of light that does not have a dramatic effect but ...

A newly identified driver of melanoma growth not only promotes tumor blood supply but also helps tumors evade immune attack.

SkylineDx today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its Clinical Practice Guidelines in Oncology ...

In a study published in February 2026 in JCO Oncology Practice, investigators from Sweden report that influenza vaccination during treatment with immune checkpoint inhibitors was associated with ...

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best immunotherapy stocks to buy according to hedge funds. On February 5, Goldman Sachs lifted the price target on Iovance Biotherapeutics Inc.